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Abstract
Background: The post-genomic era has brought new challenges regarding the understanding of the organization 
and function of the human genome. Many of these challenges are centered on the meaning of differential gene 
regulation under distinct biological conditions and can be performed by analyzing the Multiple Differential Expression 
(MDE) of genes associated with normal and abnormal biological processes. Currently MDE analyses are limited to usual 
methods of differential expression initially designed for paired analysis.
Results: We proposed a web platform named ProbFAST for MDE analysis which uses Bayesian inference to identify key 
genes that are intuitively prioritized by means of probabilities. A simulated study revealed that our method gives a 
better performance when compared to other approaches and when applied to public expression data, we 
demonstrated its flexibility to obtain relevant genes biologically associated with normal and abnormal biological 
processes.
Conclusions: ProbFAST is a free accessible web-based application that enables MDE analysis on a global scale. It offers 
an efficient methodological approach for MDE analysis of a set of genes that are turned on and off related to functional 
information during the evolution of a tumor or tissue differentiation. ProbFAST server can be accessed at http://
gdm.fmrp.usp.br/probfast.
Background
Transcriptome analysis of a tissue or cell type has been
widely used since the development of methodological
approaches for the large-scale study of gene expression
such as SAGE [1], MPSS [2], Microarray [3]. The next-
generation sequencing technology has been adapted to
transcriptome analysis and the ability to accurately mea-
sure mRNA signals must provide unprecedented impact
on gene expression analysis [4,5]. Thus, it is accepted that
high-throughput data represents the starting point to
predict further our understanding of molecular disorders
associated with the physiopathology of a given pheno-
type.
The most classical application to the analysis of gene
expression focuses on the identification of genes differen-
tially expressed between two biological conditions. At
this stage, a large number of statistical tests is used for a
precise identification of candidate genes [6,7]. The net-
work of biological processes involved in the evolution of a
tumor or in tissue differentiation is extremely complex
and requires the development of mathematical models
for a simultaneous analysis of a set of genes in two or
more biological conditions. Analyses of this nature are
currently performed using standard methods designed
for paired analyses. Thus, it is highly necessary to develop
methods for analysis of multiple expression of a gene. We
shall define the approach in the current study as Multiple
Differential Expression (MDE).
An example of the application of MDE approach may
be illustrated by the following question: what genes have
shown an increasing level of expression in three libraries
(A, B and C) representing the stages (evolution) of a
tumor? To answer this question, the usual procedure
analyses couples of libraries separately and makes con-
junctions or disjunctions of the relations found, e.g. A > B
AND B > C. In fact, this analysis is traditionally used to
select any g gene with an expression profiles such as Ag >
Bg > Cg. In this type of paired analysis, the main problem
is the sensitivity and specificity of statistical tests used to
detect what genes are differentially expressed [8]. These
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Page 2 of 9statistical measures are closely related to the concepts of
type I and type II errors and they are potentiated when
more than two biological conditions are analyzed simul-
taneously. To address this shortfall, we introduced a
Bayesian model to compute the generalization of the
pairwise comparisons in order to perform MDE analysis.
It is a new probabilistic method for targeted gene selec-
tion on two or more classes through an intuitive approach
involving a question formulation process, and a probabil-
ity linked to it. In summary, all genes in accordance with
the previously formulated question will be ordered on the
basis of the probability that the question is true.
We presented a web-based system named Probabilistic
Functional Analysis System Tool (ProbFAST) that per-
mits suitable MDE analysis on a global scale. This tool
differs from others [8-11] by permitting the investigator
to analyze the global gene expression in different biologi-
cal conditions using private and/or public data, integrat-
ing it into a set of functional pieces of information
including Gene Ontology [12], KEGG [13] and Biocarta
[14]. Within this context, the tool becomes useful for the
disclosure of genes related to biological processes that are
active during the cell differentiation and growth, as well
as during organogenesis. ProbFAST is designed primarily




ProbFAST is a tool which uses the client-server architec-
ture [Additional file 1: Supplemental Figure 1]. The back-
end consists of a set of MySQL [15] relational tables that
store functional information extracted from the KEGG,
BioCarta and Gene Ontology repositories. Furthermore,
all the expression data of Gene Expression Omnibus
(GEO) [16] generated by the counting technique are
stored, including 1,800 SAGE and MPSS libraries of
approximately 40 species. All databases are monthly
updated, ensuring the access to the most recent informa-
tion. The server side is composed of three main interfaces
that enable remote use with convenient data uploading
and result visualization features.
The analysis starts with a friendly interface for the
inclusion of the project name and parameters to the pre-
processing and upload of libraries (Figure 1). In the
upload process, two options are available: 1) import data
from GEO: a search interface allows displaying a list of
expression profile experiments related to organism and
keywords filter, and 2) the upload option to analyze a new
experiment that is not included in the GEO database. To
do that, the user needs to submit a file with a predefined
format (detailed information on file format is available at
the help page). The file may be uploaded compressed in
gz, zip, or rar format. The gene identifiers supported by
ProbFAST include NCBI ID, gene symbol, tag sequence
or Unigene accession.
After the submission, users must formulate question(s)
by a comprehensive frame box and define the parameters
for enrichment analysis (Figure 2). The parameters are
preconfigured and can be adjusted according to their
stringency criterion. Finally, after processing the user will
be informed about the result by e-mail. The results are
provided in three analysis aspects:
• Gene search: The user can select one of the ques-
tions formulated and adjust the probability (cutoff ) of
interest. All genes will be listed according to the cut-
off related to the question (Figure 3).
• Enrichment analysis: This option permits the user to
select the question formulated and the functional cat-
egory of interest. The result will reveal the enriched
functional categories ordered according to the level of
significance (Sig) (Figure 4).
• Functional screening: The functional categories
with the largest number of genes with probability
above the predefined cutoff will be listed here (Figure
5).
In the options Enrichment analysis and Functional
screen, the functional categories can be ordered accord-
ing to the total expression level, total number of genes
and enrichment score (only Enrichment analysis).
By clicking on the +Info key, a window will appear with
the sum of the expression levels of the genes related to the
formulated question. Several links will permit the user to
access external information about the genes and the func-
tional categories.
The web interface is implemented in the PERL lan-
guage and the Common Gateway Interface (CGI) proto-
col was used to permit the access to the services of data
submission and result visualization. The web interface is
based on the new technology Web 2.0 AJAX.
Statistical analysis
The data obtained by counting techniques such as SAGE,
MPSS, RNAseq and the next-generation sequencing
technologies generate a simple enumeration measure-
ment that can be modeled in a probabilistic manner. The
expression of a given gene G (which, for the sake of sim-
plicity will be considered implicitly pre-determined and
the extra notation avoided) in the ith experiment is esti-
mated by the abundance of messenger RNA levels
(mRNAs) π and is commonly modeled by a Bernoulli
Process [17]. This means that the probability of observing
a tag for that gene is proportional to ? and we see the
sequencing processes as if it was a urn. Inside this imagi-
nary urn, the different colored balls would represent dif-
ferent tags and the number of each ball in the urn is
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would be easier to determine the probability L of observ-
ing N tags after sequencing a total of T tags:
where N are the counts for a specific tag that is the
proxi for the considered gene, T is the total number of
sequenced tags and C is a constant for which the actual
value is not relevant.
The following urn-like model is well-known in Bayesian
statistics and the inference about the abundance π is per-
formed, with the aid of an uniform prior, using Baye's
rule:
L N T C N T N( | , ) ( )( )p p p= − −1 (1)
f N T L N T L N p T dp( | , ) ( | , ) / ( | , )p p= ∫0
1
(2)
Figure 1 Screenshot of ProbFAST input data page. To add a new analysis, the user must add the project name and set up the pre processing in-
formation (optional). Next, the user must choose organism, platform and loading gene expression sample from GEO and/or upload the data.
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where a = N + 1, b = T - N + 1 and B(a, b) =
.
or in usual statistical notation:
Here we extended this basic model by considering a
mixture of beta densities as a way to encode the informa-
tion from several sequenced libraries (e.g. patients, indi-
viduals, treatment, etc) from the same group (e.g. cancer,
normal, drugX, etc):
where
B is the beta special function, ai = Ni + 1, bi = Ti - Ni + 1,
the sub-index i denotes the ith library and m is the num-
ber of libraries that compose a single group, i.e. the com-
ponents of the mixture. Note that there is no sub-index to
denote a gene (or tag) in these equations because it is
implicit that a given gene is our focus.
It is somewhat easy to derive an estimate for a given
probabilistic question provided that one knows how to
generate random deviates from all atomic parts of the
question. If the group at hand is composed of just one
library m = 1, then the model reduces itself to the usual
beta random variable which can be easily simulated. On
the other hand, for a real mixture (e.g. more than 1
patient in the class "cancer", for example) m > 1, the simu-
lation can be more computationally expensive, but also
easy. Our mathematical code implemented in R language
automatically switches between these two modes and
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Figure 2 Creating question. Now, the user needs to specify one or more target question. For that, work layer allows choosing sample and question 
operators to help creating the question. Double click on the sample name allows set pool analysis.
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atomic elements in the probabilistic question are in place,
the probability estimation is trivial: , where St is simu-
lations number for which the question returns true and
Sn is the total number of simulations.
To assess the efficiency of our method, comparing it to
approaches reported in the literature [8,18-20], we per-
formed a simulation study [Additional file 1: Supplemen-
tal Figure 2 and Figure 3]. The sensitivity and specificity
of all methods were evaluated and compared by receiver
operating characteristic (ROC) curves [21].
To perform MDE analysis with data generated by
counting techniques, we developed the probMDE algo-
rithm to compute the generalization of the paired analy-
ses according to the probabilistic model above. The R
code, with the complete and self-contained implementa-
tion of our model, can be downloaded in [22].
Next, using these probabilistic results, we incorporated
enrichment analysis for the functional categories Gene
Ontology, KEGG, and BIOCARTA using the methods
and source-code available by the tool ProbCD [23]. This
is an efficient approach for considering the rate of error
included in all annotation process [24]. The user can also
upload other probabilistic annotation values for the func-
tional categories available in ProbFAST. The statistical
significance for the enrichment is obtained as in ProbCD
tool [23]: a null distribution for the statistical association
measure is created using a randomization approach. The
measured association is then compared with the null to
derive p-values. A term is significantly over-represented
(or equivalently, the gene list is enriched) depending on
the user-defined thresholds for significance and/or asso-
ciation.
Results and Discussion
To evaluate the efficacy of ProbFAST in order to provide
meaningful insights biologically, we first compared the
results obtained by ProbFAST with data previously
reported in the literature [25]. We also found new targets
when reanalyzing public dataset. We showed three of sev-
eral applications of ProbFAST. All the results presented
St
Sn
Figure 3 Gene search. Firstly, users can select the question target and cutoff value through the Gene Search panel. Then the genes associated ques-
tion and cutoff will be showed. By clicking on any image from functional categories it enables the user to visualize indexed information on the layer 
in the right side. Key-word filters can be applied in order to refine results.
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and 11850212008 respectively at the Visualize Analysis
section at the website of the project [26].
1) Up and down-regulation
Lee et al [25] measured the effect of radiofrequency (RF)
on gene expression at the genome level. They observed
that using RF of 2.45 GHz, 221 genes presented abnormal
gene expression after 2h of exposure and 759 genes
showed abnormal expression after 6h of exposure. Using
gene expression as the indicator to determine if there
were any biological effect of RF, three samples were used
for the analysis: a control with 2h sham exposure
(GSM66698), a sample of HL-60 cells exposed for 2h
(GSM66712) and a sample exposed for 6h (GSM66714).
We used the same data set and raised two questions to
offer a genome-wide scenario of genes that were up-regu-
lated on (GSM66698 <GSM66712 <GSM66714) and
down-regulated on (GSM66698 > GSM66712 >
GSM66714). We launched into ProbFAST all the tags
reported by those authors and we divided the results into
up and down-regulated ones. Afterwards, we selected the
first 50 genes with a cutoff > = 70 criterion from each
group obtained by our analysis and compared them to the
genes reported by the authors. We were able to obtain the
same genes reported by Lee et al [25] and, fortunately, we
were able to observe new genes that have not been
described by those authors. Such genes changed their
expression due to RF exposure. Among the new genes we
would like to describe PTMA and EIF5 genes that were
down and up-regulated respectively.
Prothymosin-alpha or PTMA (MIM: 188390) was iden-
tified in the thymus gland while producing several hor-
mones or hormone-like substances known as
prothymosin-alpha. Regarding its role, Jiang et al [27]
identified a pathway that regulates mitochondria-initi-
ated caspase activity. In this pathway, PTMA negatively
regulates caspase-9 activation by inhibiting apoptosome
formation. Elimination of PTMA expression by RNA
interference sensitized cells to ultraviolet irradiation-
induced apoptosis. Another example of the relation
between the PTMA gene and the radiosensitivity is the
finding of Ojima et al [28], who used microarray to deter-
mine if the expression levels of specific genes could pre-
dict clinical radiosensitivity in human colorectal cancer.
They found that PTMA was up-regulated in the resistant
cell lines and suggested that PTMA may be a novel
Figure 4 Enrichment analysis. An example of the enriched functional term list output for KEGG category. The resulting enriched KEGG pathways 
can be visualized using a table consisting of enrichment cutoff values of the enriched terms (with web links to additional information), total of the 
relevant annotated genes and counting of transcripts.
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clinical cases of colorectal cancer.
The other gene revealed by ProbFAST was eukaryotic
translation initiation factor 5 A or EIF5A (MIM:600187).
EIF5A is an essential protein tightly linked to cellular
homeostasis, and its protein may be also involved in
nucleocytoplasmic mRNA transport. Recent studies have
indicated that EIF5A may play a role in cell death, as its
over-expression was found to induce apoptosis in lung
cancer [29]. All these reports corroborate the role of
these genes in regulating the apoptosis process. In addi-
tion, both are modulated by radiation or RF exposure.
These findings are good examples of which genes should
be found by a functional analysis tool and we would like
to emphasize that ProbFAST was able to detect these
genes.
2) Next-Generation Sequencing
Currently, the Next-Generation Sequencing is more fre-
quently found in laboratories and these laboratories must
be able to deal with a great amount of data from this new
high-throughput platform. We carried out an analysis to
detect which genes were up-regulated (N <S2 <S4) in
human Solexa LongSAGE from Cancer Genome Anat-
omy Project SAGE library collection. Three samples were
used: a control N - skin normal/GSM384135, S2 - stage 2
melanoma skin/GSM384132 and S4 - stage 4 melanoma
skin/GSM384133.
We have detected some genes from MAGE family such
as MAGED1, MAGED2, MAGEF1, MAGEH1; these
genes show that ProbFAST is able to detect genes accu-
rately once they are melanoma associated antigens and
they are expected to be found in the question N <S2 <S4.
Another expected gene was MCAM which is a melanoma
cell adhesion molecule and it was also detected by Prob-
FAST. Interesting was the detection of RGS1 and SPP1
genes. Both genes were detected as over-expressed genes
in melanoma and data from literature has already
reported that both genes are considered great markers for
melanoma while investigating malignant melanoma and
benign nevi [30].
3) Analysis of one or more groups of biological replicates
ProbFAST tool is also able to analyze groups of libraries.
In order to prove this skill, we selected four SAGE librar-
ies and the analysis was performed while clustering the
Figure 5 Functional Screening. The functional categories presenting the largest number of genes with values above the cutoff related to the ques-
tion will be listed here.
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one group and two normal libraries (GSM383869 and
GSM383870) within the other group. The question
loaded to ProbFAST was (GSM383859, GSM383860 >
GSM383869, GSM383870). The analysis was performed
with 80% probability cutoff.
We found a group of transcriptions factors and the
most expressed were TGFBI, SRCAP, GTF2A1L and
SOX12. TGFBI proteins can modulate cell adhesion due
to its inhibition [31]. GTF2A1L protein has a role in the
assembly and stability of the RNA polymerase II tran-
scription pre-initiation complex on a eukaryotic core pro-
moter [32]. SOX proteins are implicated in cell fate
decisions in a wide range of developmental processes.
SOX transcription factors have diverse tissue-specific
expression patterns during early development and it was
proposed that they acted target-specific transcription
factors and/or as chromatin structure regulatory ele-
ments. SOX12 expression in various tissues also suggests
a role in both differentiation and maintenance of several
cell types [33].
We also detected a group of genes highly expressed in
the tumoral libraries which has a direct role in tumori-
genesis. These genes are BRMS1, GREB1 and PRR5.
BRMS1 reduces the metastatic potential, but not the
tumorogenicity of human breast cancer and melanoma
cell lines [34,35]. GREB1 is an estrogen-responsive gene
that is an early response gene in the estrogen receptor-
regulated pathway. This gene may play an important role
in hormone-responsive tissues and cancer [36]. PRR5
gene encodes a protein with a proline rich domain. This
gene is located in a region of chromosome 22 reported as
containing a tumor suppressor gene that may be involved
in breast and colorectal tumorigenesis [37].
Our tool also detected some other genes more
expressed in the tumoral libraries and have important
roles in cell progression, proliferation and differentiation.
These genes are TRIM28, BP1, CAD and S100A6.
TRIM28 gene encodes a protein that mediates transcrip-
tional control by interaction with a repression domain
found in many transcription factors. There are new find-
ings suggesting that this transcriptional repressor plays a
role in cell proliferation [38]. BP1 gene is also a member
of a family of translation repressor proteins. This gene
has been already reported as having a role in the progres-
sion of breast neoplasms through cell signaling [39]. On
the other hand, CAD gene encodes a protein which is
required by mammalian cells to proliferate [40]. S100A6
proteins are located in the cytoplasm and/or nucleus of a
wide range of cells, and are involved in the regulation of a
number of cellular processes such as cell cycle progres-
sion and differentiation. S100A6 is also associated with
human colorectal adenocarcinoma tumorigenesis and
invasion/metastasis [41].
Conclusions
ProbFAST is a web application that facilitates the analysis
of enumeration gene expression data generated by high-
throughput technologies. It supports a flexible Bayesian
method that assigns a probability for each gene analyzed
according to a previously defined question, and aims to
bring a top-down approach to carry out MDE analysis
according to the investigator's background.
Future directions
ProbFAST currently supports statistical analysis for enu-
meration data and our goal is to extend this capability for
microarray data.
Availability and requirements
• Project Name: ProbFAST - Probabilistic Functional
Analysis System Tool
• Project Home Page: http://gdm.fmrp.usp.br/prob-
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• Other requirements: MySQL
• License: GNU General Public License
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